Diabetic Macular Edema

>

Latest News

Ashvattha announces positive topline data for MGB for the treatment of DME and nAMD
Ashvattha announces positive topline data for MGB for the treatment of DME and nAMD

September 4th 2025

An eye on how patients perceive their retinal disease
An eye on how patients perceive their retinal disease

August 24th 2025

VivaVision Biotech appoints Quan Dong Nguyen to its scientific advisory board
VivaVision Biotech appoints Quan Dong Nguyen to its scientific advisory board

August 21st 2025

Lupin and Sandoz sign licensing deal for biosimilar ranibizumab across multiple regions
Lupin and Sandoz sign licensing deal for biosimilar ranibizumab across multiple regions

August 14th 2025

4DMT reports positive SPECTRA results in DME trial
4DMT reports positive SPECTRA results in DME trial

August 8th 2025

Latest CME Events & Activities

More News

Several cyst characteristics linked to ischemia in DME

Several cyst characteristics linked to ischemia in DME

Michelle Dalton, ELS
September 30th 2019

SWAP-TWO shows anatomic improvement after switch to aflibercept

SWAP-TWO shows anatomic improvement after switch to aflibercept

Michelle Dalton, ELS
September 17th 2019

ASRS 2019 Street Team: Rishi P. Singh, MD

ASRS 2019 Street Team: Rishi P. Singh, MD

OT Staff Reports
August 28th 2019

ICYMI: Dr. Singh shares the take-home message from his 2019 presentation

Meta-analysis on DME treatments updated to include treatment regimen

Meta-analysis on DME treatments updated to include treatment regimen

August 27th 2019

Anti-VEGFs pose no additional risk of SAEs over other therapies

Anti-VEGFs pose no additional risk of SAEs over other therapies

Michelle Dalton, ELS
August 19th 2019

retina risk app

Retina risk app tool empowers diabetic patients worldwide

Lynda Charters
August 1st 2019

diabetic retinopathy

Obesity + diabetic retinopathy: Korean study explores inverse association

Lynda Charters
July 16th 2019

diabetic retinopathy genetics

DNA analysis: Unraveling role of genetics in DR pathogenesis

Lynda Charters
July 16th 2019

Diabetic retinopathy

Lipid-lowering drugs, lower DR risk may go hand in hand

Lynda Charters
July 1st 2019

Anti-VEGF expansion treats all DR stages

Anti-VEGF expansion treats all DR stages

Michelle Dalton, ELS
June 14th 2019

Laser treatment for DME: Still a place at the table

Laser treatment for DME: Still a place at the table

Lynda Charters
June 3rd 2019

Site Logo

Mini Quiz: Educating patients about DME

May 30th 2019
Determining DR progression: Much work still needs to be done

Determining DR progression: Much work still needs to be done

Lynda Charters
May 21st 2019

Image-reading accuracy Increases with deep-learning DR algorithms

Image-reading accuracy Increases with deep-learning DR algorithms

Lynda Charters
May 14th 2019

Laser’s place in diabetic retinopathy: Choosing the right scenario

Laser’s place in diabetic retinopathy: Choosing the right scenario

Lynda Charters
April 1st 2019

Successful PDR outcomes driven by strict adherence to follow-up

Successful PDR outcomes driven by strict adherence to follow-up

Lynda Charters
April 1st 2019

Managing uveitic macular edema

Managing uveitic macular edema

Lynda Charters
March 6th 2019

Intravitreal triamcinolone acetonide, dexamethasone implant superior for regional treatment of disorder

Cataract surgery in patients with diabetes: No time like the present

Cataract surgery in patients with diabetes: No time like the present

Lynda Charters
March 1st 2019

Real-world study of the fluocinolone acetonide implant show its benefits for treating DME

Real-world study of the fluocinolone acetonide implant show its benefits for treating DME

Cheryl Guttman Krader, BS, Pharm
January 11th 2019

When vitrectomy offers a viable therapeutic option for DME

When vitrectomy offers a viable therapeutic option for DME

Cheryl Guttman Krader, BS, Pharm
November 26th 2018

Anatomic outcome more precise in defining DME treatment failure

Anatomic outcome more precise in defining DME treatment failure

November 13th 2018

Targeting angiopoietin-2 + VEGF-A to treat DME

Targeting angiopoietin-2 + VEGF-A to treat DME

Cheryl Guttman Krader, BS, Pharm
November 5th 2018

Site Logo

Imaging and Retinal Disorders

Michelle Dalton, ELS
October 19th 2018

Findings from the PERMEATE study used novel diagnostics to quantify response to intravitreal injections

Site Logo

The subthreshold laser’s role in retinal vascular disease

Netan Choudhry, MD
October 18th 2018

Combination therapy benefits from laser in the mix for DME, other conditions

A study shows Alzheimer’s disease biomarkers in the vitreous

A study shows Alzheimer’s disease biomarkers in the vitreous

Michelle Dalton, ELS
October 7th 2018

Anti-VEGFs can improve DRSS in majority of patients

Anti-VEGFs can improve DRSS in majority of patients

Michelle Dalton, ELS
September 14th 2018

Site Logo

Risuteganib for the treatment of DME

August 16th 2018

Light induced visual-response: Objective, functional vision testing

Light induced visual-response: Objective, functional vision testing

Steven M. Silverstein, MD, FACS
August 16th 2018

PDR patients manifest decreased in CPD

Diabetic eye disease advances, but questions remain

Michelle Dalton, ELS
August 7th 2018

Factoring in that patients require continual and constant monitoring, maintenance

Two drugs better than one in DME therapy?

Two drugs better than one in DME therapy?

Michelle Dalton, ELS
July 25th 2018

A phase II clinical trial evaluating suprachoroidal CLS-TA used with intravitreally administered aflibercept in patients with diabetic macular edema (DME) over a 6-month evaluation period-has met both primary and secondary endpoints of vision and anatomic improvement. 

<1
...
89101112131415>
© 2025 MJH Life Sciences

All rights reserved.